To make an appointment, please call 1-800-KARMANOS (1-800-527-6266) or request an appointment online
As a leader in cancer research, Karmanos is able to offer patients access to innovative treatments and clinical trials that are often times not available anywhere else.
To offer hope and longer life to patients with all types of cancer, Karmanos offers the latest types of therapy through our clinical trials program. Through clinical trials, we are creating new knowledge about how therapies fight cancer and provide national leadership in testing these new therapies.
We understand that cancer is a complex disease that demands complex care. We provide each patient with a dynamic, carefully constructed treatment plan focused on their specific cancer and their unique needs.
We listen to you to design a plan that provides you with respect, compassionate care and is responsive to your emotional and practical concerns.
Education is provided to all patients and their family members through the New Patient Portfolio distributed to each new patient at Karmanos.
We offer classes on specific treatments and procedures, on-demand videos, special programs and additional literature.
Because cancer is a growing community health concern, Karmanos Cancer Institute provides valuable information regarding prevention and early detection of cancer. Our experts present information on cancer prevention, risk and its reduction, and testing guidelines. Programs are available to businesses, religious congregations and social/community groups in southeastern Michigan.
The Education and Resource Center (ERC) is a patient and family-focused health library with the latest information on cancer care, including disease and treatment information, coping and support, integrative medicine and prevention. Resources found in the ERC include:
The Education and Resource Center (ERC) is located on the first floor of the Wertz Clinic at Karmanos Cancer Center in Detroit. The ERC is open Monday-Friday from 8:30 a.m.-4:30 p.m.
For Gen Sheng Wu, Ph.D., a member of the Molecular Therapeutics Research Program at the Barbara Ann Karmanos Cancer Institute and professor in the...
Among American men, prostate cancer is the most commonly diagnosed cancer and the second leading cause of cancer-related death after lung cancer. ...
The Barbara Ann Karmanos Cancer Institute , along with cancer centers and other organizations across the nation, recognizes and promotes awa...